Innova Captab Limited (INNOVACAP.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹1,062.60 (+6.45%) as of
Key statistics
- Market cap
- 60.81B
- P/E (TTM)
- 39.92
- Forward P/E
- 23.43
- EPS (TTM)
- 26.62
- Dividend yield
- 0.40%
- 52-week range
- 622.00 – 1,353.50
- Beta
- -0.03
- Revenue (TTM)
- 17.49B
- Profit margin
- 8.81%
- Analyst target
- ₹1,116.00
- Volume
- 71.81k
About Innova Captab Limited
Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies. It is also offers various generic formulation products, including cephalosporins, proton pump inhibitor, anticholinergic and heparin NSAIDs, analgesics and antipyretic, anticold and antiallergic, antiemetic, antidiabetic, antispasmodic, antifibrinolytic, cardiovascular, antioxidant and vitamins, antihyperuricemia and antigout, fluoroquinolone and macrolide, nootropics and neurotonics/neurotrophics, antiulcerative, antimalarial anxiolytic, anticonvulsant and antipsychotic, bladder and prostate disorder, antifungal, anthelmintic and antiviral, anticholinergic, anti-asthmatic, and bronchodilator products in the form of tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. The company sells its branded generic products through a network of distributors, stockists, and pharmacies, as well as online channels in various e-commerce pharmacy sites. Innova Captab Limited was incorporated in 2005 and is based in Panchkula, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Panchkula, India
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.